Loading...
Loading...
Fluidigm Corporation
FLDM, a supplier of microfluidic systems for
growth markets in the life science and agricultural biotechnology industries,
today announced that it has closed the previously announced underwritten
public offering of 4,209,000 shares of its common stock at a price to the
public of $14.25 per share for gross proceeds of approximately $60 million.
The shares include 549,000 shares of common stock sold pursuant to the
over-allotment option granted by Fluidigm to the underwriters, which option
was exercised in full. The net proceeds from the sale of the shares, after
deducting the underwriters' discounts and commissions and other estimated
offering expenses payable by Fluidigm, will be approximately $56.1 million.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in